IVDR technical documentation software

IVDR technical documentation software

Coming soon. Build, review and maintain your IVDR technical documentation and performance evaluation in one AI workspace. Join the early access list.

Your IVDR technical documentation needs to demonstrate that your in vitro diagnostic device is safe and performs as intended. Evidence is often scattered across Word files, spreadsheets and SharePoint folders. Coming soon, Obodux IVDR will bring technical documentation and performance evaluation into one AI workspace for your team to build, review and maintain.

It is being developed for teams preparing a first IVDR submission, transitioning legacy IVDD devices to IVDR, or maintaining documentation throughout the device lifecycle. Join the early access list to hear when it is available.

Every part of your IVDR documentation, in one place

Obodux IVDR is being built around Annex II technical documentation, Annex III post-market surveillance and Annex XIII performance evaluation, so your evidence can be organised against the relevant requirements.

Device description and specification

Intended purpose, analytes, specimen types, variants and UDI information, with a Class A, B, C or D classification rationale under IVDR Annex VIII.

Labelling and IFU

Labels, instructions for use and translations, consistent with the IVD’s intended purpose, users and performance claims.

Design and manufacturing

Design stages, manufacturing sites, suppliers and key processes documented under Annex II.

GSPR checklist

Applicable IVDR Annex I General Safety and Performance Requirements mapped to standards and supporting evidence.

Risk management (ISO 14971)

Risk management plan, hazard analysis and benefit-risk conclusions linked to performance evidence and the rest of the documentation.

Performance evaluation (Annex XIII)

Performance evaluation plan and report bringing together scientific validity, analytical performance and clinical performance evidence.

Verification and validation

Analytical and clinical performance studies, specimen stability, software validation and other verification evidence relevant to your IVD.

Post-market surveillance and PMPF

Annex III PMS documentation: PMS reports for Class A and B, PSURs for Class C and D, and Annex XIII post-market performance follow-up (PMPF) plans and reports.

How Obodux IVDR will work

  1. Bring in what you already have

    Upload existing documentation for organisation against IVDR Annex II, III and XIII.

  2. See the gaps

    Identify missing or referenced-but-absent evidence against the IVDR structure. You can also request a free gap analysis to discuss your current documentation.

  3. Draft with AI assistance

    Planned guided templates and AI drafting will help address gaps. Every suggestion will remain yours to review, edit and approve.

  4. Get specialist review

    Plan specialist review of your IVDR documentation and performance evaluation where a second pair of eyes is needed.

  5. Keep it current

    Keep PMS findings, PMPF outputs and performance evaluation updates connected as evidence changes, with planned version history and an audit trail.

Obodux compared with the usual approaches

Word and SharePointConsultant onlyObodux IVDR (coming soon)
StructureFolder structure you design and maintainDepends on the consultantPlanned around IVDR Annex II, III and XIII
Finding gapsManual cross-checkingPaid review, usually point in timePlanned IVDR evidence gap analysis
DraftingFrom scratch or old templatesWritten for you, at day ratesPlanned AI-assisted drafting your team controls
Expert inputNone built inYesSpecialist review planned for IVDR documentation
Audit trailLimited version historyHeld by the consultantPlanned change history in one workspace

Who it is for

  • Small and mid-sized IVD manufacturers preparing for the EU market
  • RA/QA leads and founders assembling IVDR technical documentation and performance evidence
  • Teams transitioning legacy IVDD devices to IVDR
  • Manufacturers of Class A to D IVDs classified under Annex VIII, including teams also considering UKCA documentation for Great Britain

Common questions

Does Obodux replace our ISO 13485 QMS?

No. Obodux IVDR is being developed to sit alongside your quality management system and focus on technical documentation. Your QMS procedures and document control remain your responsibility.

Will Obodux IVDR support the IVDD to IVDR transition?

That is the planned focus: organise legacy IVDD documentation, identify gaps against IVDR Annex II and III, and assemble Annex XIII performance evaluation and PMPF evidence. Our guide to MDR and IVDR transition deadlines explains the timelines.

Will using Obodux guarantee CE marking?

No. Obodux is a documentation tool with optional specialist review. It does not provide legal or regulatory advice, and your organisation remains responsible for its technical documentation and submissions.

How do we try it?

Obodux IVDR is coming soon. Join early access to register your interest; IVDR access is not yet available.

IVDR documentation software is coming soon

Join the early access list for Obodux IVDR, or request a free gap analysis to discuss your current documentation.

Join early accessGet a free gap analysis

Ready for IVDR technical documentation?

Ready for IVDR technical documentation?

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880

Obodux is a SaaS platform that streamlines medical device compliance. Using AI tools and a secure workspace, it helps prepare CE, UKCA, and global documentation faster, stay audit-ready, and launch products confidently.

Compliance Disclaimer: Obodux provides tools to assist with regulatory compliance but does not guarantee regulatory approval. Users remain responsible for ensuring their compliance with applicable regulations.

Cyber Essentials Certified

© 2026 Obodux. All rights reserved. Obodux is the MedTech compliance product from BORIS Software Ltd.

Obodux, a product of BORIS Software Ltd
Turing House, 120 Millshaw, Beeston, Leeds LS11 8LZ, United Kingdom
Tel: 03300 414880